Skip to content
BOLUS
Subscribe

Signal from the log

Emerald

1,4 M£ · United Kingdom · Health services

Emerald, à Londres, propose via les employeurs un bilan sanguin en clinique, une application qui réunit résultats et données de montres connectées, et un généraliste attitré qui peut prescrire. Sur 1,4 M£, la moitié est une subvention Innovate UK et aucun chef de file n'est nommé.

Spotted

Announced on , logged by the watch of 20 October 2026.

Operation
Funding round
Announced amount
1,4 M£
Country
United Kingdom
Sector
Health services

What the log says

Editorial note, in French

Repérée par la collecte. Personne ne l'a encore instruite.

The investors

With Boost Capital Partners , Sequel , Highgoal Capital

What is missing before publishing
  • The stage of the round is not disclosed. A letter is never inferred from an amount or a track record.
Provenance
Logged on 20 October 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Spotted The collection saw this operation and logged it. Nobody has processed it yet, so what is shown is still an automatic reading of the source headline.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.

One address, nothing else.

One letter a week, on Fridays: the week's funding rounds, the funds named, the amounts double checked. The list is never sold, one click to unsubscribe. The letter is written in French.

You are, if you care to say

Email confirmation before any subscription. The list is never sold. What Bolus knows about you is written on the privacy page (in French).